Assessing the Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Undiagnosed Young Adults:A Cross Sectional Study

April 21, 2024 updated by: Aina Marzia Syed, Jinnah Sindh Medical University
To asses the prevalence of Attention deficit hyperactivity disrorder in undiagnosed young adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Finding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) in undiagnosed young adults using the questionnaire provided by WHO ,

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Sindh
      • Karachi, Sindh, Pakistan, 75330
        • JSMU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Young adults between age group of 18-24

Description

Inclusion Criteria:

  • undiagnosed

Exclusion Criteria:

  • diagnosed with any mental disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Age group
18-20 21-22 22-24
ASRS V1.1 scores(%)
Score of Ahdh self report scale questionnaire
Behavioral: Behavioral diagnostic
Diagnosing the behavioral pattern
ADHD symptom prevalence
People who got more than 4 in part A of questionnaire and more than 6 in Part B
Behavioral: Behavioral diagnostic
Diagnosing the behavioral pattern

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the prevalence of undiagnosed ADHD in Young adults
Time Frame: 2 months
To find out the prevalence of ADHD in Young adults
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Jinnah Sindh Medical University

Investigators

  • Principal Investigator: Aina M Syed, Jinnah Sindh Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

September 1, 2023

Study Completion (Actual)

September 1, 2023

Study Registration Dates

First Submitted

April 21, 2024

First Submitted That Met QC Criteria

April 21, 2024

First Posted (Actual)

April 25, 2024

Study Record Updates

Last Update Posted (Actual)

April 25, 2024

Last Update Submitted That Met QC Criteria

April 21, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 009-0001-7719-1189

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Finding the Prevalence of ADHD in Undiagnosed Young Adults

Clinical Trials on Behavioral diagnostic

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe